Actively Recruiting
Using Machine Learning to Differentiate Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome in Adults
Led by Fondazione IRCCS Policlinico San Matteo di Pavia · Updated on 2025-12-10
60
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying patients with eosinophilic granulomatosis with polyangiitis EGPA and hypereosinophilic syndrome HES to collect clinical, laboratory, and instrumental data. The goal is to use artificial intelligence to identify characteristics that differentiate these two diseases and predict how patients might respond to treatment. This study aims to improve diagnosis and treatment decision-making for these conditions. Participants will undergo blood draws for laboratory assessments as part of the study procedures. These data will be analyzed using machine learning techniques to find meaningful differences between EGPA and HES. The study focuses on gathering information rather than testing a new drug or treatment. During the study, participants will provide clinical and laboratory data, including blood samples. Researchers will monitor these data over an 18-month period to identify distinct disease features. The study involves no masking or placebo, and participants will be followed to assess characteristics that separate the two conditions. The total participation time corresponds to the data collection period of 18 months.
CONDITIONS
Brief Title
The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome
Research Team
C
Carlomaurizio Montecucco
A
Alessandra Milanesi
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here